272 related articles for article (PubMed ID: 21522127)
1. USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1.
Zhang X; Berger FG; Yang J; Lu X
EMBO J; 2011 Jun; 30(11):2177-89. PubMed ID: 21522127
[TBL] [Abstract][Full Text] [Related]
2. USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2.
Li Z; Hao Q; Luo J; Xiong J; Zhang S; Wang T; Bai L; Wang W; Chen M; Wang W; Gu L; Lv K; Chen J
Oncogene; 2016 Jun; 35(22):2902-12. PubMed ID: 26411366
[TBL] [Abstract][Full Text] [Related]
3. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy.
He B; Zhao YC; Gao LC; Ying XY; Xu LW; Su YY; Ji QQ; Lin N; Pu J
Hypertension; 2016 Jun; 67(6):1237-48. PubMed ID: 27045030
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice.
Kon N; Zhong J; Qiang L; Accili D; Gu W
J Biol Chem; 2012 Feb; 287(7):5102-11. PubMed ID: 22187431
[TBL] [Abstract][Full Text] [Related]
6. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor.
Zhang L; Zhou F; Drabsch Y; Gao R; Snaar-Jagalska BE; Mickanin C; Huang H; Sheppard KA; Porter JA; Lu CX; ten Dijke P
Nat Cell Biol; 2012 Jun; 14(7):717-26. PubMed ID: 22706160
[TBL] [Abstract][Full Text] [Related]
7. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.
Qi CF; Kim YS; Xiang S; Abdullaev Z; Torrey TA; Janz S; Kovalchuk AL; Sun J; Chen D; Cho WC; Gu W; Morse Iii HC
Int J Mol Sci; 2012; 13(5):6204-6219. PubMed ID: 22754359
[TBL] [Abstract][Full Text] [Related]
8. USP4 inhibits SMAD4 monoubiquitination and promotes activin and BMP signaling.
Zhou F; Xie F; Jin K; Zhang Z; Clerici M; Gao R; van Dinther M; Sixma TK; Huang H; Zhang L; Ten Dijke P
EMBO J; 2017 Jun; 36(11):1623-1639. PubMed ID: 28468752
[TBL] [Abstract][Full Text] [Related]
9. p53 ubiquitination: Mdm2 and beyond.
Brooks CL; Gu W
Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
[TBL] [Abstract][Full Text] [Related]
10. Nuclear-cytoplasmic shuttling of the oncogenic mouse UNP/USP4 deubiquitylating enzyme.
Soboleva TA; Jans DA; Johnson-Saliba M; Baker RT
J Biol Chem; 2005 Jan; 280(1):745-52. PubMed ID: 15494318
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis.
Xing C; Lu XX; Guo PD; Shen T; Zhang S; He XS; Gan WJ; Li XM; Wang JR; Zhao YY; Wu H; Li JM
Cancer Res; 2016 Jan; 76(1):83-95. PubMed ID: 26669864
[TBL] [Abstract][Full Text] [Related]
12. Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.
Wang L; He G; Zhang P; Wang X; Jiang M; Yu L
Mol Biol Rep; 2011 Jan; 38(1):229-36. PubMed ID: 20333547
[TBL] [Abstract][Full Text] [Related]
13. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
[TBL] [Abstract][Full Text] [Related]
14. The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest.
Corcoran CA; Huang Y; Sheikh MS
Cancer Biol Ther; 2004 Aug; 3(8):721-5. PubMed ID: 15280670
[TBL] [Abstract][Full Text] [Related]
15. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
16. Up-regulated deubiquitinase USP4 plays an oncogenic role in melanoma.
Guo W; Ma J; Pei T; Zhao T; Guo S; Yi X; Liu Y; Wang S; Zhu G; Jian Z; Gao T; Li C; Liao W; Shi Q
J Cell Mol Med; 2018 May; 22(5):2944-2954. PubMed ID: 29542252
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
Wang W; Takimoto R; Rastinejad F; El-Deiry WS
Mol Cell Biol; 2003 Mar; 23(6):2171-81. PubMed ID: 12612087
[TBL] [Abstract][Full Text] [Related]
18. AKT regulation of mesothelial-to-mesenchymal transition in peritoneal dialysis is modulated by Smurf2 and deubiquitinating enzyme USP4.
Xiao L; Peng X; Liu F; Tang C; Hu C; Xu X; Wang M; Luo Y; Yang S; Song P; Xiao P; Kanwar YS; Sun L
BMC Cell Biol; 2015 Mar; 16():7. PubMed ID: 25885904
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic protein UnpEL/Usp4 deubiquitinates Ro52 by its isopeptidase activity.
Wada K; Tanji K; Kamitani T
Biochem Biophys Res Commun; 2006 Jan; 339(3):731-6. PubMed ID: 16316627
[TBL] [Abstract][Full Text] [Related]
20. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.
Kamijo T; van de Kamp E; Chong MJ; Zindy F; Diehl JA; Sherr CJ; McKinnon PJ
Cancer Res; 1999 May; 59(10):2464-9. PubMed ID: 10344759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
